AstraZeneca

AstraZeneca PLC is a global, science-led biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines for some of the world’s most serious diseases. Founded in 1999 through the merger of Sweden’s Astra AB and the United Kingdom’s Zeneca Group, the company is headquartered in Cambridge, England. AstraZeneca operates in more than 100 countries and has established itself as a leader in oncology, cardiovascular diseases, respiratory medicine, immunology, rare diseases, and vaccines.

The company combines advanced biology, genomics, precision medicine, artificial intelligence, and data science to accelerate drug development and improve patient outcomes. AstraZeneca has one of the industry’s strongest pipelines in oncology and rare diseases, supported by extensive research collaborations with universities, biotechnology companies, and healthcare organizations worldwide.

AstraZeneca maintains a global network of research centers, manufacturing facilities, and commercial operations that adhere to strict quality and regulatory standards. The company is committed to sustainability, responsible manufacturing, carbon reduction initiatives, and expanding access to healthcare in both developed and emerging markets.

Through continuous investment in innovation, advanced technologies, and scientific partnerships, AstraZeneca remains one of the world’s most influential pharmaceutical companies, delivering transformative therapies that improve and extend patients’ lives globally.